Home  |  Important Safety Information  |  Full Prescribing Information PDF
Contact Us  |  Site Map
A
A
A
Print

Patient Education Materials

Download and print these helpful documents for your patients


   
Download the Three-Month Migraine Tracker
Your patients can use this tool to track their migraine pain over the course of three months. Use it to gauge the effectiveness of pain management techniques and therapies.
 
   
Download FROVA® Patient Product Information
Patient Product Information is a user-friendly alternative to the Full Prescribing Information for patients who want to know more about treatment with FROVA, including dosing information and frequently asked questions.

 Get Adobe® Reader®

The most common side effects associated with the use of FROVA are dizziness, fatigue, paresthesia, flushing, headache, dry mouth, hot or cold sensation, skeletal pain, chest pain, and dyspepsia.
+ View references
  1. Kelman L. Pain characteristics of the acute migraine attack. Headache. 2006;46(6):942-953. doi:10.1111/j.1526-4610.2006.00443.x.
  2. Malik SN, Hopkins M, Young WB, Silberstein SD. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache. 2006;46(5):773-780. doi:10.1111/j.1526-4610.2006.00437.x.
  3. Headache Classification Subcommittee of the International Headache Society (IHS). The international classification of headache disorders, 2nd edition, 1st revision (ICHD-IIR1). http://ihs-classification.org/_downloads/mixed/ICHD-IIR1final.doc. Updated May 2005. Accessed March 5, 2009.
  4. Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine. Cephalalgia. 1991;11(1):1-12.
  5. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646-657.
  6. Cady R, Elkind A, Goldstein J, Keywood C. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate to severe. Curr Med Res Opin. 2004;20(9):1465-1472. doi:10.1185/030079904X2745.
  7. Ryan R, Geraud G, Goldstein J, Cady R, Keywood C. Clinical efficacy of frovatriptan: placebo-controlled studies. Headache. 2002;42(suppl 2):S84-S92.
  8. FROVA® [package insert]. Chadds Ford, PA: Endo Pharmaceuticals, Inc; 2007.
  9. Physicians' Desk Reference. 63rd ed. Montvale, NJ: Physicians' Desk Reference Inc; 2008.
  10. RELPAX® [package insert]. New York, NY: Pfizer Inc. Available online at: https://www.pfizerpro.com/product_info/relpax_pi_clinical_pharmacology.jsp. Accessed January 8, 2009.
     

    Important Safety Information

    For more information, please see Full Prescribing Information for FROVA at http://www.frova.com/pi.